Triclabendazole

三氯苯达唑

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTriclabendazole
Drug Alias NameEgatenFasinexTriclatheraCGA-89317EGA-230B +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA (cytosine-5)-methyltransferase 1 inhibitors
TargetsDNA (cytosine-5)-methyltransferase 1
Therapy Area/IndicationsFascioliasis
Global Approved IndicationsFascioliasis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIran
Original Approved Date1989/01/01
Country/TerritoryUnited StatesIran
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Ag
Inactive CompaniesN/A
Active IndicationsFascioliasis
Inactive IndicationsN/A

Other Information

ATC CodeP02BX04
Related LinksWikipediaDrugBankKEGG